We are live on ! Find out more
CP

Castleview Partners Portfolio holdings

AUM $228M
1-Year Est. Return 19.85%
This Fund
S&P 500
This Quarter Est. Return
+6.32%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
10 Year Est. Return
AUM
$179M
AUM Growth
+$36.4M
Cap. Flow
+$27.1M
Cap. Flow %
15.1%
Top 10 Hldgs %
30.18%
Holding
955
New
94
Increased
315
Reduced
139
Closed
58

Sector Composition

Rank Sector Weight
1 Technology 8.46%
2 Consumer Discretionary 7.87%
3 Healthcare 6.43%
4 Financials 5.98%
5 Industrials 3.49%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRK icon
176
Merck
MRK
$324B
$201K 0.11%
1,523
+345
+29% +$42.5K
RTX icon
177
RTX Corp
RTX
$295B
$200K 0.11%
2,049
+85
+4% +$7.67K
BMY icon
178
Bristol-Myers Squibb
BMY
$130B
$200K 0.11%
3,681
+1,199
+48% +$61.1K
PYPL icon
179
PayPal
PYPL
$50.7B
$199K 0.11%
2,971
-6,235
-68% -$383K
CSCO icon
180
Cisco
CSCO
$450B
$195K 0.11%
3,905
+668
+21% +$33.3K
XOP icon
181
State Street SPDR S&P Oil & Gas Exploration & Production ETF
XOP
$3.52B
$195K 0.11%
1,257
+1,149
+1,064% +$159K
LYB icon
182
LyondellBasell Industries
LYB
$19.6B
$192K 0.11%
1,881
+487
+35% +$47.4K
AVTR icon
183
Avantor
AVTR
$9.7B
$190K 0.11%
7,435
+4,478
+151% +$107K
KMX icon
184
CarMax
KMX
$8.54B
$187K 0.1%
2,148
-58
-3% -$4.39K
BAX icon
185
Baxter International
BAX
$12.7B
$186K 0.1%
4,358
+2,891
+197% +$118K
QCOM icon
186
Qualcomm
QCOM
$169B
$186K 0.1%
1,098
+28
+3% +$4.33K
XBI icon
187
State Street SPDR S&P Biotech ETF
XBI
$10B
$185K 0.1%
1,950
+1,839
+1,657% +$171K
PFE icon
188
Pfizer
PFE
$144B
$185K 0.1%
6,665
+1,786
+37% +$49.6K
GILD icon
189
Gilead Sciences
GILD
$167B
$180K 0.1%
2,458
+819
+50% +$63K
BIZD icon
190
VanEck BDC Income ETF
BIZD
$1.61B
$180K 0.1%
10,630
+3,304
+45% +$54K
K
191
DELISTED
Kellanova
K
$179K 0.1%
3,124
+1,027
+49% +$56.6K
CL icon
192
Colgate-Palmolive
CL
$74.5B
$178K 0.1%
1,981
+522
+36% +$44.2K
VNQ icon
193
Vanguard Real Estate ETF
VNQ
$39.9B
$173K 0.1%
1,997
+1,607
+412% +$137K
DUK icon
194
Duke Energy
DUK
$101B
$171K 0.1%
1,763
+459
+35% +$43.5K
YMAG icon
195
YieldMax Magnificent 7 Fund of Option Income ETFs
YMAG
$275M
$170K 0.1%
+8,330
New +$170K
APD icon
196
Air Products & Chemicals
APD
$65.6B
$169K 0.09%
699
+46
+7% +$11.3K
AXP icon
197
American Express
AXP
$226B
$169K 0.09%
743
+22
+3% +$4.56K
LNG icon
198
Cheniere Energy
LNG
$54B
$167K 0.09%
1,035
-337
-25% -$54.2K
FITB
199
Fifth Third Bancorp
FITB
$51.7B
$161K 0.09%
4,339
+1,017
+31% +$35.4K
SPYM
200
State Street SPDR Portfolio S&P 500 ETF
SPYM
$159B
$159K 0.09%
2,578
+314
+14% +$18.4K

Similar funds

Castleview Partners's Q1 2024 Portfolio in Review

As of Q1 2024, Castleview Partners held 955 positions worth $179M, up 25% from $143M the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Castleview Partners deployed $27.1M of net new capital in Q1 2024, opening 94 new positions and adding to 315 existing holdings. Its largest new stake was Regan Floating Rate MBS ETF: 877,935 shares worth $22.2M.

By sector, the portfolio is most concentrated in Technology at 8.5% of assets, down from 8.5% a quarter earlier, followed by Consumer Discretionary and Healthcare.

On the sell side, the largest reduction was Acruence Active Hedge US Equity ETF, an estimated $24.4M trimmed.

  • Castleview Partners's largest Q1 2024 buy was Regan Floating Rate MBS ETF: 877,935 shares worth $22.2M.
  • Castleview Partners added most to Apple in Q1 2024, an estimated $2.31M increase.
  • Castleview Partners's biggest Q1 2024 reduction was Acruence Active Hedge US Equity ETF, cutting an estimated $24.4M.
  • Castleview Partners fully exited Columbia EM Core ex-China ETF in Q1 2024, selling an estimated $265K.
  • Castleview Partners's ten largest holdings make up 30% of its $179M portfolio in Q1 2024.
  • Castleview Partners opened 94 new positions and closed 58 in Q1 2024.
  • Castleview Partners's portfolio value rose 25% quarter-over-quarter to $179M.

Based on Castleview Partners's 13F filing for Q1 2024, filed 10 May 2024.